Skip to main navigation Skip to search Skip to main content

High Asymptomatic Carriage With the Omicron Variant in South Africa

  • on behalf of the Ubuntu Study Team
  • University of Kwazulu-Natal
  • Fred Hutchinson Cancer Center
  • Washington University in St Louis
  • South African Medical Research Council
  • Bio Analytical Research Corporation South Africa and Lancet Laboratories
  • NIAID National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • University of Pretoria
  • University of Washington
  • Qhakaza Mbokodo Research Clinic
  • University of Cape Town

Research output: Contribution to journal › Article › peer-review

66 Citations (Scopus)

Abstract

We report a 23% asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) Omicron carriage rate in participants being enrolled into a clinical trial in South Africa, 15-fold higher than in trials before Omicron. We also found lower CD4+T-cell counts in persons with human immunodeficiency virus (HIV) strongly correlated with increased odds of being SARS-CoV-2 polymerase chain reaction (PCR) positive.

Original languageEnglish
Pages (from-to)E289-E292
JournalClinical Infectious Diseases
Volume75
Issue number1
DOIs
Publication statusPublished - 1 Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • asymptomatic carriage
  • Omicron variant
  • PWH
  • SARS-CoV-2
  • South Africa

Fingerprint

Dive into the research topics of 'High Asymptomatic Carriage With the Omicron Variant in South Africa'. Together they form a unique fingerprint.

Cite this